Drug intelligence / Profile preview

equilin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Vaginal
01

Overview

Equilin is a naturally occurring estrogenic steroid hormone found in horses and used as a medication. It is one of the principal estrogens present in conjugated estrogen preparations such as Premarin and esterified estrogens. Equilin acts primarily as an estrogen receptor agonist but has lower affinity for the receptor compared to estradiol. It promotes growth and development of female reproductive tissues and secondary sex characteristics. In vitro studies show that equilin inhibits 17β-hydroxysteroid dehydrogenase type 1, which catalyzes the conversion of estrone to estradiol. Equilin also displays endothelium-independent vasodilator effects by blocking L-type calcium channels on vascular smooth muscle cells. Additionally, it has been shown to promote cortical neuron growth via an NMDA receptor-dependent mechanism. Equilin is a major component (20–30%) of conjugated equine estrogens used for hormone replacement therapy in postmenopausal women.

Other names
1,3,5,7-estratetraen-3-ol-17-one7-dehydroestronedihydroequilenin3-hydroxyestra-1,3,5(10),7-tetraen-17-one
02

Targets

HSD17B1 (Hydroxysteroid 17-beta dehydrogenase 1)ESR1 (ERα)ESR2 (ERβ)LTCC (Voltage-gated calcium channel (L-type))GPER1 (G protein-coupled estrogen receptor 1)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on equilin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on equilin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call